Works matching IS 09509232 AND DT 2009 AND VI 28 AND IP 46

Results: 8

p210<sup>Bcr−Abl</sup> desensitizes Cdc42 GTPase signaling for SDF-1α-directed migration in chronic myeloid leukemia cells.

Published in:

Oncogene, 2009, v. 28, n. 46, p. 4105, doi. 10.1038/onc.2009.260

By:

Chang, Y.-C.;
Tien, S.-C.;
Tien, H.-F.;
Zhang, H.;
Bokoch, G. M.;
Chang, Z.-F.

Publication type:

Article

The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene.

Published in:

Oncogene, 2009, v. 28, n. 46, p. 4041, doi. 10.1038/onc.2009.259

By:

Chua, Y. L.;
Ito, Y.;
Pole, J. C. M.;
Newman, S.;
Chin, S.-F.;
Stein, R. C.;
Ellis, I. O.;
Caldas, C.;
O'Hare, M. J.;
Murrell, A.;
Edwards, P. A. W.

Publication type:

Article

The DEAD-box protein p72 regulates ERα-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERα-positive breast cancer.

Published in:

Oncogene, 2009, v. 28, n. 46, p. 4053, doi. 10.1038/onc.2009.261

By:

Wortham, N. C.;
Ahamed, E.;
Nicol, S. M.;
Thomas, R. S.;
Periyasamy, M.;
Jiang, J.;
Ochocka, A. M.;
Shousha, S.;
Huson, L.;
Bray, S. E.;
Coombes, R. C.;
Ali, S.;
Fuller-Pace, F. V.

Publication type:

Article

The neuroblastoma tumour-suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells.

Published in:

Oncogene, 2009, v. 28, n. 46, p. 4075, doi. 10.1038/onc.2009.256

By:

Farina, A. R.;
Tacconelli, A.;
Cappabianca, L.;
Cea, G.;
Chioda, A.;
Romanelli, A.;
Pensato, S.;
Pedone, C.;
Gulino, A.;
Mackay, A. R.

Publication type:

Article

PU.1 induces apoptosis in myeloma cells through direct transactivation of TRAIL.

Published in:

Oncogene, 2009, v. 28, n. 46, p. 4116, doi. 10.1038/onc.2009.263

By:

Ueno, S.;
Tatetsu, H.;
Hata, H.;
Iino, T.;
Niiro, H.;
Akashi, K.;
Tenen, D. G.;
Mitsuya, H.;
Okuno, Y.

Publication type:

Article

GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.

Published in:

Oncogene, 2009, v. 28, n. 46, p. 4126, doi. 10.1038/onc.2009.262

By:

Luo, W.;
Gangwal, K.;
Sankar, S.;
Boucher, K. M.;
Thomas, D.;
Lessnick, S. L.

Publication type:

Article

Suppression of lung adenocarcinoma through menin and polycomb gene-mediated repression of growth factor pleiotrophin.

Published in:

Oncogene, 2009, v. 28, n. 46, p. 4095, doi. 10.1038/onc.2009.273

By:

Gao, S.-B.;
Feng, Z.-J.;
Xu, B.;
Wu, Y.;
Yin, P.;
Yang, Y.;
Hua, X.;
Jin, G.-H.

Publication type:

Article

Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells.

Published in:

Oncogene, 2009, v. 28, n. 46, p. 4065, doi. 10.1038/onc.2009.274

By:

Song, B.;
Wang, Y.;
Xi, Y.;
Kudo, K.;
Bruheim, S.;
Botchkina, G. I.;
Gavin, E.;
Wan, Y.;
Formentini, A.;
Kornmann, M.;
Fodstad, O.;
Ju, J.

Publication type:

Article